258 related articles for article (PubMed ID: 7933861)
21. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
22. [Preventive lymphadenectomy in complex treatment of melanoma of the skin, trunk and extremities].
Akhmetov IR; Vazhenin AV; Iaĭtsev SV; Privalov AV
Vestn Khir Im I I Grek; 2011; 170(1):11-4. PubMed ID: 21506347
[TBL] [Abstract][Full Text] [Related]
23. [Combined and complex treatment of patients with II-stage malignant skin melanoma using hyperthermia].
Zhavrid EA; Fradkin SZ; Bezruchko VI; Firmanchuk AV; Proleskovskiĭ AK
Vopr Onkol; 1986; 32(3):52-7. PubMed ID: 3962258
[TBL] [Abstract][Full Text] [Related]
24. Liver resection in multimodal concepts improves survival of metastatic melanoma: a single-centre case-matched control study.
Hau HM; Tautenhahn HM; Schoenberg MB; Atanasov G; Wiltberger G; Morgül MH; Uhlmann D; Seitz AT; Simon JC; Schmelzle M; Bartels M
Anticancer Res; 2014 Nov; 34(11):6633-9. PubMed ID: 25368268
[TBL] [Abstract][Full Text] [Related]
25. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
Richtig E; Ludwig R; Kerl H; Smolle J
Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis-oriented therapy of malignant melanoma. New concepts].
Garbe C; Stadler R; Orfanos CE
Hautarzt; 1986 Jul; 37(7):365-72. PubMed ID: 3744822
[TBL] [Abstract][Full Text] [Related]
27. Assessment of survival rates with metastatic malignant melanomas.
Goldman LI; Elder D; Clark WH; Mastrangelo MJ; Stennett J
Surg Gynecol Obstet; 1986 Mar; 162(3):199-203. PubMed ID: 3952612
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
29. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.
Veronesi U; Adamus J; Aubert C; Bajetta E; Beretta G; Bonadonna G; Bufalino R; Cascinelli N; Cocconi G; Durand J; De Marsillac J; Ikonopisov RL; Kiss B; Lejeune F; MacKie R; Madej G; Mulder H; Mechl Z; Milton GW; Morabito A; Peter H; Priario J; Paul E; Rumke P; Sertoli R; Tomin R
N Engl J Med; 1982 Oct; 307(15):913-6. PubMed ID: 7050717
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment of melanoblastoma in a child].
Litovka VK; Zhurilo IP; Kononuchenko VP
Klin Khir; 1995; (7-8):52. PubMed ID: 8624953
[No Abstract] [Full Text] [Related]
32. Sentinel-node biopsy in melanoma.
Lipsker D
N Engl J Med; 2007 Jan; 356(4):419; author reply 419-21. PubMed ID: 17256190
[No Abstract] [Full Text] [Related]
33. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
[No Abstract] [Full Text] [Related]
34. Can histologic parameters of melanoma metastases in sentinel lymph nodes reliably select patients who can be safely spared completion lymph node dissection?
Murali R; Thompson JF; Scolyer RA
Ann Surg; 2010 Jun; 251(6):1188-9; author reply 1189-90. PubMed ID: 20485116
[No Abstract] [Full Text] [Related]
35. [Study of the sentinel lymph node. Diagnosis and treatment of cutaneous malignant melanoma stages I and II].
Denninghoff V; Falco J; Curutchet HP; Elsner B
Medicina (B Aires); 2006; 66(2):144-6. PubMed ID: 16715764
[TBL] [Abstract][Full Text] [Related]
36. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
37. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
38. Survival with regional and distant metastases from cutaneous malignant melanoma.
Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
[TBL] [Abstract][Full Text] [Related]
39. High frequency of brain metastases after adjuvant therapy for high-risk melanoma.
Samlowski WE; Moon J; Witter M; Atkins MB; Kirkwood JM; Othus M; Ribas A; Sondak VK; Flaherty LE
Cancer Med; 2017 Nov; 6(11):2576-2585. PubMed ID: 28994212
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
